Future-focused breast health leader will highlight recent
advancements with interactive booth experiences, workshops and symposia
MARLBOROUGH, Mass.--(BUSINESS WIRE)--
Hologic, Inc. (Nasdaq: HOLX) will showcase its expanding suite of breast
and skeletal health products, including screening, interventional,
ultrasound and surgical solutions, in Booth #2511 at the 104th
Scientific Assembly and Annual Meeting of the Radiological Society of
North America (RSNA) at McCormick Place in Chicago from Nov. 25 to 29.
The pioneer behind the Genius™ 3D Mammography™ exam, Hologic has
expanded significantly in recent years to offer innovations across the
entire clinical continuum of breast health. These new products range
from the SmartCurve™ breast stabilization system and Clarity HD
high-resolution 3D™ imaging technology, to the Viera™ portable breast
ultrasound and Brevera® breast biopsy system with CorLumina®
imaging technology, which features real-time imaging and sample
verification. In addition, two recent acquisitions of Faxitron®
Bioptics, a leader in digital specimen radiography, and Focal
Therapeutics, manufacturer of the BioZorb® marker, have
enabled Hologic to play a larger role in breast conserving surgery and
strengthened its offerings to radiologists, pathologists and breast
surgeons.
“As a world leader in mammography, we have built our breast and skeletal
health division on a foundation of breakthrough solutions proven to
improve cancer detection, patient satisfaction and facility workflow,
and reduce costs associated with unnecessary callbacks,” said Pete
Valenti, Hologic’s Division President, Breast and Skeletal Health
Solutions. “We have spent the past several years thoughtfully expanding
this portfolio through a commitment to insight-driven innovation and
strategic acquisitions that align with our mission. Now we can make a
positive impact on breast health at each step of a patient’s journey –
from screening to pathology. We look forward to using our time at RSNA
to highlight how Hologic plans to continue to lead the industry forward
as the partner of choice to meet the increasing number of unmet and
changing needs of our customers and their patients.”
During the show, Hologic will host a number of workshops and a CME
symposium, Contrast Enhanced Mammography: Incorporating CEM Into Your
Clinical Practice, led by Bhavika Patel, MD and Chief, Breast
Imaging Section, Department of Radiology, Mayo Clinic. Workshops will
focus on a variety of topics including synthesized 2D imaging
technology, real-time breast specimen imaging, breast density assessment
and screening, tomosynthesis-guided prone biopsy solutions, and a
clinical perspective on implementing the Genius exam and SmartCurve
system. In addition, interactive booth highlights will include:
-
The Breast Biopsy Innovation Suite, featuring Hologic’s
complete range of biopsy solutions designed to deliver improved
patient satisfaction, better clinician workflow, and facility cost
savings. Visitors to the suite can participate in hands-on
demonstrations of LOCalizer™, Hologic’s new wireless radiofrequency
identification (RFID) breast lesion localization system, and the
Viera™ portable breast ultrasound system.
-
An A.I. Future Suite highlighting Hologic’s longstanding
commitment to incorporating artificial intelligence and machine
learning into its groundbreaking technologies. Attendees will
experience current and future applications of A.I. in breast imaging,
and learn more about how Hologic plans to continue delivering
significant value as a leader in the space.
-
The opportunity to take the Clarity Challenge to identify cases
featuring Hologic’s new Clarity HD high-resolution 3D™ imaging
technology. This technology provides the industry's fastest, highest
resolution 3D™ images to accelerate screening and analysis, and is
designed to clearly reveal subtle lesions and fine calcifications to
help pinpoint cancers early. Attendees will be encouraged to review
cases displayed on multiple workstations to determine which were
obtained using this new technology, and view the challenge results in
real-time.
Visitors to Hologic’s booth also will have access to the Company’s
entire suite of breast and skeletal health products, including a number
of new innovations that were introduced earlier this year, such as the
3Dimensions™ Mammography System and Fluoroscan® Insight™ FD
Mini C-Arm. The 3Dimensions system, the fastest, highest resolution
breast tomosynthesis system to date, provides higher resolution 3D™
images for radiologists, enhanced workflow for technologists, and a more
comfortable mammography experience, with low-dose options, for patients.1
The enhanced Fluoroscan system adds to Hologic’s portfolio of
market-leading skeletal imaging solutions. It offers a variety of
improved features designed to arm orthopedists, podiatrists and
clinicians with diversified imaging options, more flexible storage and
transport, and an enhanced interface.
RSNA is an international society of radiologists, medical physicists and
other medical professionals with 55,000 members from more than 140
countries. The RSNA Annual Meeting is expected to attract more than
60,000 attendees. For more information or to RSVP for a workshop or
symposium, please visit HologicRSNA.com
or stop by the Hologic booth #2511 or Faxitron booth #1916.
The Genius™3D Mammography™exam (also known as
the Genius™ exam) is only available on a Hologic®3D
Mammography™system. It consists of a 2D and 3D™image
set, where the 2D image can be either an acquired 2D image or a 2D image
generated from the 3D™image set. There are more than 5,000
Hologic 3D Mammography™ systems in use in the U.S. alone, so women have
convenient access to the Genius exam. To learn more about the Genius
exam, visit http://www.Genius3DNearMe.com.
About Hologic, Inc.
Hologic, Inc. is an innovative medical technology company primarily
focused on improving women’s health and well-being through early
detection and treatment. For more information on Hologic, visit www.hologic.com.
Hologic, 3D, 3D Mammography, 3Dimensions, Biozorb, Brevera, CorLumina,
Faxitron, Fluoroscan, Focal Therapeutics, Genius, Insight, LOCalizer,
SmartCurve, The Science of Sure and Viera are trademarks and/or
registered trademarks of Hologic, Inc., and/or its subsidiaries in the
United States and/or other countries.
Forward-Looking Statements
This news release may contain forward-looking information that involves
risks and uncertainties, including statements about the use of Hologic
products. There can be no assurance these products will achieve the
benefits described herein or that such benefits will be replicated in
any particular manner with respect to an individual patient, as the
actual effect of the use of the products can only be determined on a
case-by-case basis. In addition, there can be no assurance that these
products will be commercially successful or achieve any expected level
of sales. Hologic expressly disclaims any obligation or undertaking to
release publicly any updates or revisions to any such statements
presented herein to reflect any change in expectations or any change in
events, conditions or circumstances on which any such data or statements
are based.
This information is not intended as a product solicitation or promotion
where such activities are prohibited. For specific information on what
products are available for sale in a particular country, please contact
a local Hologic sales representative or write to womenshealth@hologic.com.
______________________
1 Data on file
SOURCE: Hologic, Inc.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20181123005007/en/
Media Contact:
Jane Mazur
508.263.8764
(direct)
585.355.5978 (mobile)
jane.mazur@hologic.com
Investor Contact:
Michael Watts
858.410.8588
michael.watts@hologic.com
Source: Hologic, Inc.